Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP513413.RAZ7klcgt3_5B-vNP5jpNSMZhxnFZY91qpHqNi_sl035o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP513413.RAZ7klcgt3_5B-vNP5jpNSMZhxnFZY91qpHqNi_sl035o130_assertion type Assertion NP513413.RAZ7klcgt3_5B-vNP5jpNSMZhxnFZY91qpHqNi_sl035o130_head.
- NP513413.RAZ7klcgt3_5B-vNP5jpNSMZhxnFZY91qpHqNi_sl035o130_assertion description "[These results are consistent with reports indicating that 40-50% of bone metastases of prostate cancer have wild-type p53, 50-70% do not overexpress the Bcl-2 protein, and mutations in the p21 gene are rare.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP513413.RAZ7klcgt3_5B-vNP5jpNSMZhxnFZY91qpHqNi_sl035o130_provenance.
- NP513413.RAZ7klcgt3_5B-vNP5jpNSMZhxnFZY91qpHqNi_sl035o130_assertion evidence source_evidence_literature NP513413.RAZ7klcgt3_5B-vNP5jpNSMZhxnFZY91qpHqNi_sl035o130_provenance.
- NP513413.RAZ7klcgt3_5B-vNP5jpNSMZhxnFZY91qpHqNi_sl035o130_assertion SIO_000772 10741751 NP513413.RAZ7klcgt3_5B-vNP5jpNSMZhxnFZY91qpHqNi_sl035o130_provenance.
- NP513413.RAZ7klcgt3_5B-vNP5jpNSMZhxnFZY91qpHqNi_sl035o130_assertion wasDerivedFrom befree-20140225 NP513413.RAZ7klcgt3_5B-vNP5jpNSMZhxnFZY91qpHqNi_sl035o130_provenance.
- NP513413.RAZ7klcgt3_5B-vNP5jpNSMZhxnFZY91qpHqNi_sl035o130_assertion wasGeneratedBy ECO_0000203 NP513413.RAZ7klcgt3_5B-vNP5jpNSMZhxnFZY91qpHqNi_sl035o130_provenance.